227 related articles for article (PubMed ID: 34002539)
1. Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in experimental peripartum cardiomyopathy.
Pfeffer TJ; List M; Müller JH; Scherr M; Bauersachs J; Hilfiker-Kleiner D; Ricke-Hoch M
ESC Heart Fail; 2021 Aug; 8(4):3375-3381. PubMed ID: 34002539
[TBL] [Abstract][Full Text] [Related]
2. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
Stapel B; Kohlhaas M; Ricke-Hoch M; Haghikia A; Erschow S; Knuuti J; Silvola JM; Roivainen A; Saraste A; Nickel AG; Saar JA; Sieve I; Pietzsch S; Müller M; Bogeski I; Kappl R; Jauhiainen M; Thackeray JT; Scherr M; Bengel FM; Hagl C; Tudorache I; Bauersachs J; Maack C; Hilfiker-Kleiner D
Eur Heart J; 2017 Feb; 38(5):349-361. PubMed ID: 28201733
[TBL] [Abstract][Full Text] [Related]
3. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
4. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
[TBL] [Abstract][Full Text] [Related]
5. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
Nonhoff J; Ricke-Hoch M; Mueller M; Stapel B; Pfeffer T; Kasten M; Scherr M; von Kaisenberg C; Bauersachs J; Haghikia A; Hilfiker-Kleiner D
Cardiovasc Res; 2017 May; 113(6):598-608. PubMed ID: 28453725
[TBL] [Abstract][Full Text] [Related]
6. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
[TBL] [Abstract][Full Text] [Related]
7. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.
Ricke-Hoch M; Bultmann I; Stapel B; Condorelli G; Rinas U; Sliwa K; Scherr M; Hilfiker-Kleiner D
Cardiovasc Res; 2014 Mar; 101(4):587-96. PubMed ID: 24448315
[TBL] [Abstract][Full Text] [Related]
8. [Peripartum Cardiomyopathy].
Pfeffer TJ; König T; Berliner D; Bauersachs J
Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy.
LaRocca TJ; Altman P; Jarrah AA; Gordon R; Wang E; Hadri L; Burke MW; Haddad GE; Hajjar RJ; Tarzami ST
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071921
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.
Ntusi NB; Badri M; Gumedze F; Sliwa K; Mayosi BM
PLoS One; 2015; 10(8):e0133466. PubMed ID: 26252951
[TBL] [Abstract][Full Text] [Related]
11. Adherence to heart failure treatment in patients with peripartum cardiomyopathy.
Hoevelmann J; Sliwa K; Schaar JM; Briton O; Böhm M; Meyer MR; Viljoen C
ESC Heart Fail; 2024 Jun; 11(3):1677-1687. PubMed ID: 38439175
[TBL] [Abstract][Full Text] [Related]
12. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies.
Ricke-Hoch M; Pfeffer TJ; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Mar; 116(3):520-531. PubMed ID: 31605117
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
Halkein J; Tabruyn SP; Ricke-Hoch M; Haghikia A; Nguyen NQ; Scherr M; Castermans K; Malvaux L; Lambert V; Thiry M; Sliwa K; Noel A; Martial JA; Hilfiker-Kleiner D; Struman I
J Clin Invest; 2013 May; 123(5):2143-54. PubMed ID: 23619365
[TBL] [Abstract][Full Text] [Related]
14. Peripartum cardiomyopathy.
Koenig T; Hilfiker-Kleiner D; Bauersachs J
Herz; 2018 Aug; 43(5):431-437. PubMed ID: 29767811
[TBL] [Abstract][Full Text] [Related]
15. Peripartum Cardiomyopathy.
Morris VL; Mendoza C; Stevens GS; Wilson JL; Kosoko AA
J Educ Teach Emerg Med; 2023 Apr; 8(2):S1-S34. PubMed ID: 37465654
[TBL] [Abstract][Full Text] [Related]
16. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
Sliwa K; Hilfiker-Kleiner D; Mebazaa A; Petrie MC; Maggioni AP; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; van Veldhuisen DJ; Roos-Hesslink JW; Shah AJ; Seferovic PM; Elkayam U; van Spaendonck-Zwarts K; Bachelier-Walenta K; Mouquet F; Kraigher-Krainer E; Hall R; Ponikowski P; McMurray JJ; Pieske B
Eur J Heart Fail; 2014 May; 16(5):583-91. PubMed ID: 24591060
[TBL] [Abstract][Full Text] [Related]
17. [Peripartum cardiomyopathy: a little known disease].
Scardovi AB; De Maria R
G Ital Cardiol (Rome); 2018 Apr; 19(4):209-221. PubMed ID: 29912235
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
19. Use of Impella heart pump for management of women with peripartum cardiogenic shock.
Elkayam U; Schäfer A; Chieffo A; Lansky A; Hall S; Arany Z; Grines C
Clin Cardiol; 2019 Oct; 42(10):974-981. PubMed ID: 31436333
[TBL] [Abstract][Full Text] [Related]
20. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.
McTiernan CF; Morel P; Cooper LT; Rajagopalan N; Thohan V; Zucker M; Boehmer J; Bozkurt B; Mather P; Thornton J; Ghali JK; Hanley-Yanez K; Fett J; Halder I; McNamara DM;
J Card Fail; 2018 Jan; 24(1):33-42. PubMed ID: 29079307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
